Editorial

American Heart Journal

Volumn 151, Issue 5, 2006, Pages

  Galin, Ira D ^a   Smith, Donald A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; EZETIMIBE PLUS SIMVASTATIN; LOW DENSITY LIPOPROTEIN;

CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 33748683748     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.10.009     Document Type: Letter

References (1)

1. Ballantyne C.M., Abate N., Yuan Z., et al. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study. Am Heart J 149 (2005) 464-473